HGEN / Humanigen, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Humanigen, Inc.
US ˙ OTCPK ˙ US4448632038
DIESES SYMBOL IST NICHT MEHR AKTIV

Insider-Aktien34.952.635 shares
Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

N/A

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

N/A

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

Humanigen, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in HGEN / Humanigen, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Max
Preis bei
Max
Max
Gewinn ($)
Max Rendite (%)
2022-05-20 Chappell Dale 54.549 2,2280 54.549 2,2280 121.535 52 3.0200 43.203 35,55
2022-05-20 Chappell Dale 109.098 2,2280 109.098 2,2280 243.070
2022-05-20 Chappell Dale 381.841 2,2280 381.841 2,2280 850.742
2022-05-19 Chappell Dale 32.381 2,1860 32.381 2,1860 70.785
2022-05-19 Chappell Dale 64.762 2,1860 64.762 2,1860 141.570
2022-05-19 Chappell Dale 226.665 2,1860 226.665 2,1860 495.490
2022-05-18 Chappell Dale 17.370 1,9620 17.370 1,9620 34.080
2022-05-18 Chappell Dale 34.740 1,9620 34.740 1,9620 68.160
2022-05-18 Chappell Dale 121.590 1,9620 121.590 1,9620 238.560

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

HGEN / Humanigen, Inc. Insider Trades
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in HGEN / Humanigen, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Min
Preis bei
Min
Max Verlust
Vermieden($)
Max Verlust
Vermieden(%)
2023-10-18 Chappell Dale 34.253 0,0110 34.253 0,0110 377 731
2023-10-18 Chappell Dale 75.887 0,0110 75.887 0,0110 835
2023-10-18 Chappell Dale 276.210 0,0110 276.210 0,0110 3.038
2021-06-18 Chappell Dale 30.186 18,4992 30.186 18,4992 558.417
2021-06-18 Chappell Dale 80.496 18,4992 80.496 18,4992 1.489.112
2021-06-18 Chappell Dale 291.798 18,4992 291.798 18,4992 5.398.030
2021-06-17 Chappell Dale 13.607 19,1731 13.607 19,1731 260.888
2021-06-17 Chappell Dale 36.284 19,1731 36.284 19,1731 695.677
2021-06-17 Chappell Dale 131.532 19,1731 131.532 19,1731 2.521.876

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

HGEN / Humanigen, Inc. Insider Trades
Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei
Datum
Handel
Datum
Form Insider Ticker Wertpapier-Titel Code 10b5-1 Direkt Ausführung
Preis
Einheit
Preis
Eimheiten
Verändert
Wert
Geändert (1K)
Verbleibende
Optionen
Verbleibende
Aktien
2023-10-20 2023-10-18 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 0,0110 -276.210 -3 8.398.871
2023-10-20 2023-10-18 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 0,0110 -75.887 -1 2.307.530
2023-10-20 2023-10-18 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 0,0110 -34.253 -0 1.041.536
2022-05-20 2022-05-20 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 2,2280 381.841 851 8.675.081
2022-05-20 2022-05-20 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 2,2280 109.098 243 2.383.417
2022-05-20 2022-05-20 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value P - Purchase I 2,2280 54.549 122 1.075.789
2022-05-20 2022-05-19 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 2,1860 226.665 495 8.293.240
2022-05-20 2022-05-19 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 2,1860 64.762 142 2.274.319
2022-05-20 2022-05-19 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value P - Purchase I 2,1860 32.381 71 1.021.240
2022-05-20 2022-05-18 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 1,9620 121.590 239 8.066.575
2022-05-20 2022-05-18 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 1,9620 34.740 68 2.209.557
2022-05-20 2022-05-18 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value P - Purchase I 1,9620 17.370 34 988.859
2022-03-15 2022-03-11 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 3,0000 700.000 2.100 7.944.985
2022-03-15 2022-03-11 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 3,0000 200.000 600 2.174.817
2022-03-15 2022-03-11 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value P - Purchase I 3,0000 100.000 300 971.489
2022-03-14 2022-03-09 4 Kilcoyne Adrian HGEN Common Stock P - Purchase D 2,7800 5.000 14 12.000
2022-03-14 2022-03-08 4 Kilcoyne Adrian HGEN Common Stock P - Purchase D 2,5300 7.000 18 7.000
2022-03-10 2022-03-10 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,7500 550 0 2.866
2022-03-10 2022-03-10 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,7500 157 0 818
2022-03-10 2022-03-10 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,7500 79 0 410
2022-03-10 2022-03-09 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,7870 1.026 1 2.316
2022-03-10 2022-03-09 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 1,2000 36 0 7.393
2022-03-10 2022-03-09 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,7870 293 0 661
2022-03-10 2022-03-09 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 1,2000 10 0 2.111
2022-03-10 2022-03-09 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,7870 147 0 331
2022-03-10 2022-03-09 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 2,50 1,2000 5 0 1.055
2022-03-10 2022-03-08 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 1,2000 1.668 2 7.357
2022-03-10 2022-03-08 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 1,2000 476 1 2.101
2022-03-10 2022-03-08 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 2,50 1,2000 238 0 1.050
2022-03-04 2022-03-04 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,8972 891 1 5.689
2022-03-04 2022-03-04 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,8972 255 0 1.625
2022-03-04 2022-03-04 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,8972 127 0 812
2022-03-04 2022-03-03 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,3500 1.213 0 1.290
2022-03-04 2022-03-03 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,7000 36 0 4.798
2022-03-04 2022-03-03 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,3500 346 0 368
2022-03-04 2022-03-03 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,7000 10 0 1.370
2022-03-04 2022-03-03 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,3500 173 0 184
2022-03-04 2022-03-03 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,7000 5 0 685
2022-03-04 2022-03-02 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,3255 77 0 77
2022-03-04 2022-03-02 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,5960 4.762 3 4.762
2022-03-04 2022-03-02 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,3255 22 0 22
2022-03-04 2022-03-02 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,5960 1.360 1 1.360
2022-03-04 2022-03-02 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 5,00 0,3255 11 0 11
2022-03-04 2022-03-02 4 Chappell Dale By Black Horse Capital LP HGEN Call Option (Right to Buy) P - Purchase I 2,50 0,5960 680 0 680
2022-03-04 2022-03-02 4 Durrant Cameron By Cameron Durrant Revocable Trust HGEN Common Stock P - Purchase I 2,3400 40.000 94 70.000
2022-03-04 2022-03-02 4 Jordan Edward P. HGEN Common Stock P - Purchase D 2,3200 12.500 29 12.500
2022-01-14 2022-01-12 4 MORRIS TIMOTHY E HGEN Stock Option (Right to Buy) A - Award D 2,99 59.841 59.841
2022-01-14 2022-01-12 4 Kilcoyne Adrian HGEN Stock Option (Right to Buy) A - Award D 2,99 38.411 38.411
2022-01-14 2022-01-12 4 Chappell Dale HGEN Stock Option (Right to Buy) A - Award D 2,99 36.550 36.550
2022-01-14 2022-01-12 4 Jordan Edward P. HGEN Stock Option (Right to Buy) A - Award D 2,99 43.763 43.763
2022-01-14 2022-01-12 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 2,99 84.385 84.385
2022-01-04 2021-12-31 4 Kilcoyne Adrian HGEN Stock Option (Right to Buy) A - Award D 3,72 34.500 34.500
2022-01-04 2021-12-31 4 BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 3,72 2,8400 4.163 12 4.163
2022-01-04 2021-12-31 4 Chappell Dale HGEN Stock Option (Right to Buy) A - Award D 3,72 44.600 44.600
2022-01-04 2021-12-31 4 Buxton Cheryl HGEN Stock Option (Right to Buy) A - Award D 3,72 2,8400 5.523 16 5.523
2022-01-04 2021-12-31 4 Boehm Rainer J. HGEN Stock Option (Right to Buy) A - Award D 3,72 2,8400 5.117 15 5.117
2022-01-04 2021-12-31 4 Jordan Edward P. HGEN Stock Option (Right to Buy) A - Award D 3,72 29.400 29.400
2022-01-04 2021-12-31 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 3,72 76.000 76.000
2022-01-04 2021-12-31 4 MORRIS TIMOTHY E HGEN Stock Option (Right to Buy) A - Award D 3,72 51.000 51.000
2022-01-04 2021-12-31 4 Hohneker John HGEN Stock Option (Right to Buy) A - Award D 3,72 2,8400 3.538 10 3.538
2022-01-04 2021-12-31 4 Xie Yili Kevin HGEN Stock Option (Right to Buy) A - Award D 3,72 2,8400 4.674 13 4.674
2021-11-26 2021-11-23 4 Durrant Cameron HGEN Stock Option (Right to Buy) D - Sale to Issuer D 5,93 4,5300 -17.660 -80 0
2021-11-26 2021-11-23 4 Kilcoyne Adrian HGEN Stock Option (Right to Buy) D - Sale to Issuer D 5,93 4,5300 -5.863 -27 0
2021-11-26 2021-11-23 4 Jordan Edward P. HGEN Stock Option (Right to Buy) D - Sale to Issuer D 5,93 4,5300 -4.966 -22 0
2021-10-20 2021-10-19 4 Xie Yili Kevin HGEN Stock Option (Right to Buy) A - Award D 6,56 42.866 42.866
2021-10-20 2021-10-19 4 Hohneker John HGEN Stock Option (Right to Buy) A - Award D 6,56 42.866 42.866
2021-10-04 2021-09-30 4 Jordan Edward P. HGEN Stock Option (Right to Buy) A - Award D 5,93 4.966 4.966
2021-10-04 2021-09-30 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 5,93 17.660 17.660
2021-10-04 2021-09-30 4 Chappell Dale HGEN Stock Option (Right to Buy) A - Award D 5,93 22.626 22.626
2021-10-04 2021-09-30 4 Kilcoyne Adrian HGEN Stock Option (Right to Buy) A - Award D 5,93 5.863 5.863
2021-08-27 2020-10-16 5 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) E - Other D 20,00 -80 6.532.433
2021-08-27 2020-10-13 5 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) S - Sale D 20,00 0,0938 -80 -0 6.532.433
2021-08-13 2021-08-12 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1598 -41.725 -716 7.266.296
2021-08-13 2021-08-12 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1598 -11.510 -198 1.980.696
2021-08-13 2021-08-12 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,1598 -4.316 -74 873.693
2021-08-13 2021-08-11 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0743 -79.494 -1.357 7.308.021
2021-08-13 2021-08-11 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0743 -21.929 -374 1.992.206
2021-08-13 2021-08-11 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,0743 -8.224 -140 878.009
2021-07-30 2021-07-29 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0342 -21.311 -363 7.366.204
2021-07-30 2021-07-29 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0342 -5.879 -100 2.008.256
2021-07-30 2021-07-29 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,0342 -2.204 -38 884.029
2021-07-30 2021-07-28 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0411 -7.027 -120 7.387.515
2021-07-30 2021-07-28 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0411 -1.938 -33 2.014.135
2021-07-30 2021-07-28 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,0411 -727 -12 886.233
2021-07-23 2021-07-23 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0406 -4.048 -69 7.394.542
2021-07-23 2021-07-23 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0406 -1.117 -19 2.016.073
2021-07-23 2021-07-23 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,0406 -419 -7 886.960
2021-07-23 2021-07-22 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0377 -129.054 -2.199 7.398.590
2021-07-23 2021-07-22 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0377 -35.601 -607 2.017.190
2021-07-23 2021-07-22 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,0377 -13.350 -227 887.379
2021-07-23 2021-07-21 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1366 -96.254 -1.649 7.527.644
2021-07-23 2021-07-21 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1366 -26.553 -455 2.052.791
2021-07-23 2021-07-21 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,1366 -9.957 -171 900.729
2021-07-16 2021-07-14 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0552 -11.003 -188 7.623.898
2021-07-16 2021-07-14 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0552 -3.036 -52 2.079.344
2021-07-16 2021-07-14 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,0552 -1.138 -19 910.686
2021-07-09 2021-07-09 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,3721 -214.626 -3.729 7.634.901
2021-07-09 2021-07-09 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,3721 -59.207 -1.029 2.082.380
2021-07-09 2021-07-09 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,3721 -22.203 -386 911.824
2021-07-09 2021-07-08 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1654 -34.807 -597 7.849.527
2021-07-09 2021-07-08 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1654 -9.602 -165 2.141.587
2021-07-09 2021-07-08 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,1654 -3.601 -62 934.027
2021-07-02 2021-07-02 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1200 -74.565 -1.277 7.884.334
2021-07-02 2021-07-02 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,1200 -20.569 -352 2.151.189
2021-07-02 2021-07-02 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,1200 -7.714 -132 937.628
2021-07-02 2021-07-01 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0979 -102.219 -1.748 7.958.899
2021-07-02 2021-07-01 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,0979 -28.198 -482 2.171.758
2021-07-02 2021-07-01 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,0979 -10.575 -181 945.342
2021-07-02 2021-06-30 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,2764 -158.961 -2.746 8.061.118
2021-07-02 2021-06-30 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,2764 -43.851 -758 2.199.956
2021-07-02 2021-06-30 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,2764 -16.444 -284 955.917
2021-06-25 2021-06-25 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,8035 -725.000 -12.908 8.220.079
2021-06-25 2021-06-25 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 17,8035 -200.000 -3.561 2.243.807
2021-06-25 2021-06-25 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 17,8035 -75.000 -1.335 972.361
2021-06-25 2021-06-24 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,3749 -101.158 -1.859 8.945.079
2021-06-25 2021-06-24 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,3749 -27.906 -513 2.443.807
2021-06-25 2021-06-24 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 18,3749 -10.465 -192 1.047.361
2021-06-25 2021-06-23 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,2848 -96.516 -1.765 9.046.237
2021-06-25 2021-06-23 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,2848 -26.625 -487 2.471.713
2021-06-25 2021-06-23 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 18,2848 -9.985 -183 1.057.826
2021-06-21 2021-06-18 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,4992 -291.798 -5.398 9.142.753
2021-06-21 2021-06-18 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,4992 -80.496 -1.489 2.498.338
2021-06-21 2021-06-18 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 18,4992 -30.186 -558 1.067.811
2021-06-21 2021-06-17 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,1731 -131.532 -2.522 9.434.551
2021-06-21 2021-06-17 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,1731 -36.284 -696 2.578.834
2021-06-21 2021-06-17 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 19,1731 -13.607 -261 1.097.997
2021-06-21 2021-06-16 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,4032 -111.325 -2.160 9.566.083
2021-06-21 2021-06-16 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,3996 -34.431 -668 2.615.118
2021-06-21 2021-06-16 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 19,4955 -12.730 -248 1.111.604
2021-06-16 2021-06-14 4 Durrant Cameron By Cameron Durrant Revocable Trust HGEN Common Stock S - Sale I 20,6100 -49.906 -1.029 30.000
2021-06-16 2021-06-14 4 Durrant Cameron By Cameron Durrant Revocable Trust HGEN Common Stock S - Sale I 21,1400 -5.094 -108 79.906
2021-06-16 2021-06-14 4 Durrant Cameron By Cameron Durrant Revocable Trust HGEN Common Stock S - Sale I 20,6000 -26.441 -545 85.000
2021-06-16 2021-03-01 4 Durrant Cameron By Cameron Durrant Revocable Trust HGEN Common Stock G - Gift I 111.441 111.441
2021-06-16 2021-03-01 4 Durrant Cameron HGEN Common Stock G - Gift D -111.441 0
2021-06-09 2021-06-08 4 Jordan Edward P. HGEN Stock Option (Right to Buy) M - Exercise D 9,65 -14.700 73.500
2021-06-09 2021-06-08 4 Jordan Edward P. HGEN Common Stock S - Sale D 20,0800 -14.700 -295 0
2021-06-09 2021-06-08 4 Jordan Edward P. HGEN Common Stock M - Exercise D 9,6500 14.700 142 14.700
2021-06-09 2021-06-07 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,0832 -42.440 -810 9.677.408
2021-06-09 2021-06-07 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,0832 -25.464 -486 2.649.549
2021-06-09 2021-06-07 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 19,0832 -12.732 -243 1.124.334
2021-06-04 2021-06-04 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,4635 -66.886 -1.235 9.719.848
2021-06-04 2021-06-04 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,4635 -40.132 -741 2.675.013
2021-06-04 2021-06-04 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 18,4635 -20.066 -370 1.137.066
2021-06-04 2021-06-03 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,3690 -100.607 -1.848 9.786.734
2021-06-04 2021-06-03 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 18,3690 -60.365 -1.109 2.715.145
2021-06-04 2021-06-03 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 18,3690 -30.182 -554 1.157.132
2021-06-04 2021-06-02 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,0115 -40.042 -761 9.887.341
2021-06-04 2021-06-02 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value S - Sale I 19,0115 -24.056 -457 2.775.510
2021-06-04 2021-06-02 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value S - Sale I 19,0115 -12.028 -229 1.187.314
2021-04-22 2021-04-21 4 Kilcoyne Adrian HGEN Stock Option (Right to Buy) A - Award D 14,99 155.000 155.000
2021-04-06 2021-03-09 4/A NOMIS BAY LTD. HGEN Common Stock S - Sale D 17,2374 -83.568 -1.440 5.632.469
2021-03-15 2021-03-12 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 16,07 652.640 652.640
2021-03-11 2021-03-11 4 NOMIS BAY LTD. HGEN Common Stock J - Other D 15,4900 -37.912 -587 5.342.887
2021-03-11 2021-03-11 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 16,0206 -119.201 -1.910 5.380.799
2021-03-11 2021-03-10 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 16,4646 -32.469 -535 5.500.000
2021-03-11 2021-03-09 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 17,2374 -83.568 -1.440 55.632.469
2021-03-01 2021-03-01 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 18,6490 -14.100 -263 5.616.037
2021-03-01 2021-02-26 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,1793 -30.003 -575 5.630.137
2021-03-01 2021-02-25 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,1694 -2.402 -46 5.660.140
2021-02-24 2021-02-24 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,5450 -25.906 -506 5.662.542
2021-02-24 2021-02-22 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 23,2130 -77.314 -1.795 5.688.448
2021-02-19 2021-02-19 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 23,4950 -37.300 -876 5.765.762
2021-02-19 2021-02-18 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 21,6950 -42.408 -920 5.803.062
2021-02-19 2021-02-17 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,9190 -9.700 -193 5.845.470
2021-02-16 2021-02-13 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,6810 -16.423 -323 5.855.170
2021-02-16 2021-02-11 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 21,0090 -550 -12 5.871.593
2021-02-10 2021-02-10 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 21,3890 -10.875 -233 5.872.143
2021-02-10 2021-02-09 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 22,3230 -25.666 -573 5.883.018
2021-02-10 2021-02-08 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 20,6990 -17.732 -367 5.908.684
2021-02-04 2021-02-04 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 21,8770 -47.862 -1.047 5.926.416
2021-02-04 2021-02-03 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,2330 -25.000 -481 5.974.278
2021-02-04 2021-02-02 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 20,0290 -722 -14 5.999.278
2021-01-27 2021-01-25 4 NOMIS BAY LTD. HGEN Common Stock J - Other D 18,7800 -70.000 -1.315 6.000.000
2021-01-27 2021-01-25 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,2320 -23.140 -445 6.070.000
2021-01-27 2021-01-22 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 20,0760 -71.892 -1.443 6.093.140
2021-01-21 2021-01-20 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 18,3711 -2.500 -46 6.165.032
2021-01-21 2021-01-19 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 21,0825 -6.000 -126 6.167.532
2021-01-19 2021-01-19 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,8100 -50.000 -990 6.173.532
2021-01-19 2021-01-15 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 18,2290 -30.000 -547 6.223.532
2021-01-19 2021-01-14 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 18,0660 -25.000 -452 6.253.532
2021-01-13 2021-01-12 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 18,4272 -14.577 -269 6.278.532
2021-01-13 2021-01-11 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,0000 -10.423 -198 6.293.109
2020-12-31 2020-12-28 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 22,2020 -500 -11 6.303.532
2020-12-28 2020-12-22 4/A NOMIS BAY LTD. HGEN Common Stock S - Sale D 20,0197 -50.000 -1.001 6.357.433
2020-12-28 2020-12-24 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 22,0490 -8.401 -185 6.304.032
2020-12-28 2020-12-23 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 21,0860 -45.000 -949 6.312.433
2020-12-23 2020-12-22 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 50.000,0000 -50.000 -2.500.000 6.357.433
2020-12-23 2020-12-21 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 19,4578 -25.000 -486 6.407.433
2020-12-23 2020-12-18 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) X - Other D 15,00 -46 0
2020-12-23 2020-12-18 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) X - Other D 15,00 -157 46
2020-12-23 2020-12-18 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) X - Other D 15,00 -100 203
2020-12-23 2020-12-18 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) X - Other D 15,00 -70 303
2020-12-23 2020-12-18 4 NOMIS BAY LTD. HGEN Common Stock X - Other D 15,0000 -37.300 -560 6.432.433
2020-12-23 2020-12-18 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 15,7627 -62.700 -988 6.469.733
2020-12-23 2020-12-17 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) S - Sale D 15,00 0,1533 -46 -0 373
2020-12-23 2020-12-15 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) S - Sale D 15,00 0,4000 -157 -0 327
2020-12-23 2020-12-10 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) S - Sale D 15,00 0,1000 -100 -0 170
2020-12-23 2020-12-07 4 NOMIS BAY LTD. HGEN Call Option (Obligation to sell) S - Sale D 15,00 0,1000 -70 -0 70
2020-10-07 2020-10-05 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 12,14 82.622 82.622
2020-10-02 2020-09-30 4 BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 10,64 8,0400 1.803 14 1.803
2020-10-02 2020-09-30 4 Buxton Cheryl HGEN Common Stock, $0.001 par value A - Award D 10,6400 1.284 14 4.364
2020-10-02 2020-09-30 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 10,6400 1.519 16 84.986
2020-09-22 2020-09-18 4 Chappell Dale HGEN Stock Option (right to buy) A - Award D 9,65 9,6500 133.760 1.291 133.760
2020-09-22 2020-09-18 4 Tousley David L. HGEN Stock Option (Right to Buy) A - Award D 9,65 62.700 62.700
2020-09-22 2020-09-18 4 MORRIS TIMOTHY E HGEN Stock Option (Right to Buy) A - Award D 9,65 151.316 151.316
2020-09-22 2020-09-18 4 Jordan Edward P. HGEN Stock Option (Right to Buy) A - Award D 9,65 88.200 88.200
2020-08-12 2020-08-10 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 5,0350 -17.100 -86 32.662.170
2020-07-30 2020-07-28 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 5,6550 -10.000 -57 32.679.270
2020-07-21 2020-07-20 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 5,0000 -261.915 -1.310 32.689.270
2020-07-21 2020-07-17 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 5,0050 -38.085 -191 32.951.185
2020-07-02 2020-06-30 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 4,9130 -3.000 -15 32.989.270
2020-06-17 2020-06-16 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 5,7329 -35.000 -201 32.992.270
2020-06-17 2020-06-15 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 5,5049 -30.000 -165 33.027.270
2020-06-12 2020-06-10 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 3,4770 -5.000 -17 33.057.270
2020-06-12 2020-06-09 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 3,6510 -35.000 -128 33.062.270
2020-06-12 2020-06-04 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 3,0250 -106.000 -321 33.097.270
2020-06-12 2020-06-03 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 2,9830 -101.010 -301 33.203.270
2020-06-12 2020-06-02 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 2,1810 -263.250 -574 33.304.280
2020-06-12 2020-03-20 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 2,0000 -6.000 -12 33.567.530
2020-05-22 2020-05-20 4 BARLIANT RONALD HGEN Common Stock, $0.001 par value A - Award D 0,8600 26.847 23 449.351
2020-05-21 2020-05-20 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 0,86 0,8600 250.000 215 250.000
2020-04-07 2020-04-01 4/A Savage Robert G. HGEN Stock Option (Right to Buy) A - Award D 1,20 1,2000 21.022 25 21.022
2020-04-07 2020-04-01 4/A BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 1,20 1,2000 15.340 18 15.340
2020-04-07 2020-04-02 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Convertible Note C - Conversion I 0,36 500.000,0000 0
2020-04-07 2020-04-02 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value C - Conversion I 0,3600 1.583.333 570 49.636.917
2020-04-07 2018-09-20 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Convertible Note J - Other I 0,36 500.000,0000
2020-04-02 2020-04-01 4 BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 1,20 1,2000 48.214 58 48.214
2020-04-02 2020-04-01 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 1,2000 13.750 16 417.338
2020-04-02 2020-04-01 4 Buxton Cheryl HGEN Common Stock, $0.001 par value A - Award D 1,2000 10.824 13 15.400
2020-04-02 2020-04-01 4 Savage Robert G. HGEN Stock Option (Right to Buy) A - Award D 1,20 1,2000 66.071 79 66.071
2020-01-29 2020-01-28 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 0,40 0,4000 318.103 127 318.103
2020-01-24 2020-01-22 4 BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 0,38 0,3800 50.000 19 50.000
2020-01-24 2020-01-22 4 Buxton Cheryl HGEN Common Stock, $0.001 par value A - Award D 0,3800 4.576 2 4.576
2020-01-24 2020-01-22 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 0,3800 43.421 16 403.588
2019-12-16 2019-12-16 4 Buxton Cheryl HGEN Stock Option (Right to Buy) A - Award D 0,45 715.877 715.877
2019-11-12 2019-11-08 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 0,7000 23.571 16 360.167
2019-11-12 2019-11-08 4 BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 0,70 0,5100 26.470 13 26.470
2019-07-31 2019-07-29 4 BARLIANT RONALD HGEN Common Stock, $0.001 par value A - Award D 0,8500 15.882 13 422.504
2019-07-31 2019-07-29 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 0,8500 19.412 17 336.596
2019-06-05 2019-06-04 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 1,2500 8.000 10 557.207
2019-06-04 2019-05-31 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value J - Other I 586.027 48.053.584
2019-06-04 2019-05-31 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value J - Other I 591.248 47.467.557
2019-05-31 2019-05-31 4 Durrant Cameron HGEN Common Stock, $0.001 par value J - Other D 235.624 549.207
2019-05-31 2019-05-31 4 BARLIANT RONALD HGEN Common Stock, $0.001 par value J - Other D 236.499 406.622
2019-05-30 2019-05-29 4 Boehm Rainer J. HGEN Stock Option (Right to Buy) M - Exercise D 0,66 -238.625 477.252
2019-05-30 2019-05-29 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 0,6650 238.625 159 317.184
2019-05-16 2019-05-14 4 Savage Robert G. HGEN Stock Option (Right to Buy) M - Exercise D 0,66 -100.000 615.877
2019-05-16 2019-05-14 4 Savage Robert G. HGEN Common Stock, $0.001 par value A - Award D 0,6650 100.000 66 199.869
2019-04-25 2019-04-23 4 Durrant Cameron HGEN Employee Stock Option Exercise (Right to Buy) M - Exercise D 0,66 -75.000 8.359.771
2019-04-25 2019-04-23 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,6650 75.000 50 313.583
2019-04-02 2019-03-29 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 1,3500 12.222 16 78.559
2019-04-02 2019-03-29 4 Savage Robert G. HGEN Common Stock, $0.001 par value A - Award D 1,3500 13.704 19 99.869
2019-04-02 2019-03-29 4 BARLIANT RONALD HGEN Common Stock, $0.001 par value A - Award D 1,3500 10.000 14 170.123
2019-03-11 2019-03-08 4 Durrant Cameron HGEN Employee Stock Option Exercise (Right to Buy) M - Exercise D 0,66 -75.000 8.434.771
2019-03-11 2019-03-08 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,6650 75.000 50 238.583
2019-01-28 2019-01-25 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 0,84 142.857 142.857
2019-01-28 2019-01-25 4 Jester J Gregory HGEN Stock Option (Right to Buy) A - Award D 0,84 86.111 86.111
2019-01-07 2019-01-03 4 Savage Robert G. HGEN Common Stock, $0.001 par value A - Award D 0,7400 20.946 16 86.165
2019-01-07 2019-01-03 4 BARLIANT RONALD HGEN Common Stock, $0.001 par value A - Award D 0,7400 18.243 13 160.123
2019-01-07 2019-01-03 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 0,7400 18.243 13 66.337
2018-12-14 2018-12-14 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,8160 4.000 3 163.583
2018-12-14 2018-12-12 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,8219 2.000 2 159.583
2018-12-12 2018-12-11 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,7570 2.500 2 157.583
2018-12-12 2018-12-10 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,7500 2.500 2 155.083
2018-12-10 2018-12-07 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,7390 7.000 5 152.583
2018-12-10 2018-12-06 4 Durrant Cameron HGEN Common Stock, $0.001 par value A - Award D 0,7320 10.000 7 145.583
2018-10-02 2018-09-28 4 Savage Robert G. HGEN Common Stock, $0.001 par value A - Award D 0,6400 24.219 16 65.219
2018-10-02 2018-09-28 4 BARLIANT RONALD HGEN Common Stock, $0.001 par value A - Award D 0,6400 21.094 14 141.880
2018-10-02 2018-09-28 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 0,6400 21.094 14 48.094
2018-08-09 2018-08-07 4 BARLIANT RONALD HGEN Common Stock, $0.001 par value A - Award D 0,5000 27.000 14 120.786
2018-08-09 2018-08-07 4 Savage Robert G. HGEN Common Stock, $0.001 par value A - Award D 0,5000 31.000 16 41.000
2018-08-09 2018-08-07 4 Boehm Rainer J. HGEN Common Stock, $0.001 par value A - Award D 0,5000 27.000 14 27.000
2018-03-13 3 Savage Robert G. HGEN Common Stock, $0.001 par value D 20.000
2018-03-13 3 Savage Robert G. HGEN Common Stock, $0.001 par value D 20.000
2018-03-13 2018-03-09 4 Boehm Rainer J. HGEN Stock Option (Right to Buy) A - Award D 0,66 715.877 715.877
2018-03-13 2018-03-09 4 Jester J Gregory HGEN Stock Option (Right to Buy) A - Award D 0,66 284.313 284.313
2018-03-13 2018-03-09 4 Jester J Gregory HGEN Stock Option (Right to Buy) A - Award D 0,66 1.073.815 1.223.815
2018-03-13 2018-03-09 4 BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 0,66 156.863 156.863
2018-03-13 2018-03-09 4 BARLIANT RONALD HGEN Stock Option (Right to Buy) A - Award D 0,66 715.877 715.877
2018-03-13 2018-03-09 4 Durrant Cameron HGEN Stock Option (Right to Buy) A - Award D 0,66 7.466.749 8.509.771
2018-03-13 2018-03-09 4 Savage Robert G. HGEN Stock Option (Right to Buy) A - Award D 0,66 715.877 715.877
2018-03-13 2018-03-09 4 MORRIS TIMOTHY E HGEN Stock Option (Right to Buy) A - Award D 0,66 88.235 88.235
2018-03-13 2018-03-09 4 MORRIS TIMOTHY E HGEN Stock Option (Right to Buy) A - Award D 0,66 715.877 715.877
2018-03-07 2017-09-05 4 Jester J Gregory HGEN Employee Stock Option (right to buy) A - Award D 0,33 150.000 150.000
2018-03-05 2018-02-27 4 NOMIS BAY LTD. HGEN Common Stock P - Purchase D 0,2800 29.893.424 8.370 33.573.530
2018-03-01 2018-02-27 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value P - Purchase I 0,0937 32.028.669 3.001 46.876.309
2018-03-01 2018-02-27 4 Chappell Dale By Cheval Holdings, Ltd. HGEN Common Stock, $0.001 par value J - Other I 12.812.322 14.847.640
2018-03-01 2018-02-27 4 Chappell Dale By Black Horse Capital Master Fund Ltd. HGEN Common Stock, $0.001 par value J - Other I 11.957.369 13.997.832
2018-03-01 2018-02-27 4 Chappell Dale By Black Horse Capital LP HGEN Common Stock, $0.001 par value J - Other I 5.123.733 5.996.710
2017-09-05 2017-08-30 4 NOMIS BAY LTD. HGEN Common Stock S - Sale D 0,4600 -38.900 -18 3.680.106
2017-02-22 2017-02-21 4 Lam Morgan KBIO Employee Stock Option (right to buy) A - Award D 2,92 100.000 100.000
2017-02-22 2017-02-21 4 Tousley David L. KBIO Employee Stock Option (right to buy) A - Award D 2,92 100.000 100.000
2016-09-15 2016-09-13 4 BARLIANT RONALD KBIO Stock Option (right to buy) A - Award D 3,38 100.000 100.000
2016-09-15 2016-09-13 4 MORRIS TIMOTHY E KBIO Stock Option (right to buy) A - Award D 3,38 100.000 100.000
2016-09-15 2016-09-13 4 Chappell Dale KBIO Stock Option (Right to Buy) A - Award D 3,38 100.000 100.000
2016-09-15 2016-09-13 4 Durrant Cameron KBIO Stock Option (right to buy) A - Award D 3,38 1.043.022 1.043.022
2016-09-15 2016-09-13 4 Friedberg Ezra M KBIO Stock Option (right to buy) A - Award D 3,38 100.000 100.000
2016-09-15 2016-09-13 4 Lam Morgan KBIO Stock Option (right to buy) A - Award D 3,38 100.000 100.000
2016-08-29 2016-08-26 4 Shkreli Martin KBIO Common Stock S - Sale D 3,1000 -309.723 -960 0
2016-08-29 2016-08-25 4 Shkreli Martin KBIO Common Stock S - Sale D 3,1000 -1.913.206 -5.931 309.723
2016-07-13 3 NOMIS BAY LTD. KBIOQ Common Stock D 7.438.012
2016-07-13 3 NOMIS BAY LTD. KBIOQ Common Stock D 7.438.012
2016-07-11 3 Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. KBIO Common Stock, par value $0.001 I 6.984.076
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital LP KBIO Common Stock, par value $0.001 I 5.821.735
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. KBIO Common Stock, par value $0.001 I 6.989.221
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital LP KBIO Common Stock, par value $0.001 I 5.821.735
2016-07-11 3 Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. KBIO Common Stock, par value $0.001 I 6.984.076
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital LP KBIO Common Stock, par value $0.001 I 5.821.735
2016-07-11 3 Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. KBIO Common Stock, par value $0.001 I 6.984.076
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. KBIO Common Stock, par value $0.001 I 6.989.221
2016-07-11 3 Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. KBIO Common Stock, par value $0.001 I 6.984.076
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital LP KBIO Common Stock, par value $0.001 I 5.821.735
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. KBIO Common Stock, par value $0.001 I 6.989.221
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital LP KBIO Common Stock, par value $0.001 I 5.821.735
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. KBIO Common Stock, par value $0.001 I 6.989.221
2016-07-11 3 Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. KBIO Common Stock, par value $0.001 I 6.984.076
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital LP KBIO Common Stock, par value $0.001 I 5.821.735
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. KBIO Common Stock, par value $0.001 I 6.989.221
2016-07-11 3 Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. KBIO Common Stock, par value $0.001 I 6.984.076
2016-07-11 3 Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. KBIO Common Stock, par value $0.001 I 6.989.221
2016-07-05 2016-06-30 4 BARLIANT RONALD KBIOQ Common Stock A - Award D 93.786 93.786
2016-07-05 2016-06-30 4 Durrant Cameron KBIOQ Common Stock A - Award D 135.583 135.583
2015-12-18 2015-12-16 4/A Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 29,3200 3.410 100 178.210
2015-12-18 2015-12-16 4/A Anthion Partners II LLC KBIO Common Stock P - Purchase D 29,3200 3.410 100 178.210
2015-12-18 2015-12-16 4 Fernandez Thomas Edward KBIO Common Stock P - Purchase D 29,3200 6.821 200 6.821
2015-12-18 2015-12-16 4 BIESTEK MAREK KBIO Common Stock P - Purchase D 29,3200 10.000 293 250.000
2015-12-18 2015-12-16 4 Harrison Michael Wayne KBIO Common Stock P - Purchase D 29,3200 1.705 50 1.705
2015-12-17 2015-12-16 4 Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 29,3200 3.410 100 378.210
2015-12-17 2015-12-16 4 Anthion Partners II LLC KBIO Common Stock P - Purchase D 29,3200 3.410 100 378.210
2015-11-24 2015-11-24 4 Shkreli Martin KBIO Common Stock P - Purchase D 38,1500 5.000 191 2.075.200
2015-11-23 2015-11-20 4 Shkreli Martin KBIO Common Stock P - Purchase D 18,8800 5.000 94 2.070.200
2015-11-19 3 BIESTEK MAREK KBIO Common Stock D 0
2015-11-19 2015-11-18 4 Shkreli Martin KBIO Common Stock P - Purchase D 2,0200 440.000 889 2.065.200
2015-11-19 2015-11-18 4 BIESTEK MAREK KBIO Common Stock P - Purchase D 2,0400 40.000 82 240.000
2015-11-19 2015-11-17 4 BIESTEK MAREK KBIO Common Stock P - Purchase D 1,8300 135.000 247 200.000
2015-11-19 2015-11-16 4 BIESTEK MAREK KBIO Common Stock P - Purchase D 1,3600 65.000 88 65.000
2015-11-19 2015-11-18 4 Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 2,1300 150.000 320 574.800
2015-11-19 2015-11-18 4 Anthion Partners II LLC KBIO Common Stock P - Purchase D 2,1300 150.000 320 574.800
2015-11-18 3/A Moradi David KBIO Common Stock D 67.937
2015-11-18 3/A Moradi David Through Anthion Partners II LLC KBIO Common Stock I 67.937
2015-11-18 2015-11-17 4/A Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 1,6900 113.800 192 424.800
2015-11-18 2015-11-17 4/A Anthion Partners II LLC KBIO Common Stock P - Purchase D 1,6900 113.800 192 424.800
2015-11-18 2015-11-16 4/A Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 1,7600 17.100 30 311.000
2015-11-18 2015-11-16 4/A Anthion Partners II LLC KBIO Common Stock P - Purchase D 1,7600 17.100 30 311.000
2015-11-18 2015-11-16 4/A Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 1,2600 225.963 285 293.900
2015-11-18 2015-11-16 4/A Anthion Partners II LLC KBIO Common Stock P - Purchase D 1,2600 225.963 285 293.900
2015-11-18 3 Anthion Partners II LLC KBIO Common Stock D 203.811
2015-11-18 3 Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock I 203.811
2015-11-18 3 Anthion Partners II LLC KBIO Common Stock D 203.811
2015-11-18 3 Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock I 203.811
2015-11-18 3 Shkreli Martin KBIO Common Stock D 828.170
2015-11-18 3 Shkreli Martin KBIO Common Stock D 828.170
2015-11-18 2015-11-17 4 Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 1,6900 113.800 192 424.800
2015-11-18 2015-11-17 4 Anthion Partners II LLC KBIO Common Stock P - Purchase D 1,6900 113.800 192 424.800
2015-11-18 2015-11-16 4 Anthion Partners II LLC KBIO Common Stock P - Purchase D 1,7600 17.100 30 311.000
2015-11-18 2015-11-16 4 Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 1,7600 17.100 30 311.000
2015-11-18 2015-11-16 4 Anthion Partners II LLC Through Anthion Partners II LLC KBIO Common Stock P - Purchase I 1,2600 225.963 285 293.900
2015-11-18 2015-11-16 4 Anthion Partners II LLC KBIO Common Stock P - Purchase D 1,2600 225.963 285 293.900
2015-11-18 2015-11-17 4 Shkreli Martin KBIO Common Stock P - Purchase D 2,4300 7.000 17 1.625.200
2015-11-18 2015-11-17 4 Shkreli Martin KBIO Common Stock P - Purchase D 1,9300 606.677 1.171 1.618.200
2015-11-18 2015-11-16 4 Shkreli Martin KBIO Common Stock P - Purchase D 1,4300 97.269 139 1.011.523
2015-11-18 2015-11-16 4 Shkreli Martin KBIO Common Stock P - Purchase D 0,6100 500.169 305 914.254
2015-11-10 2015-11-09 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,95 1.875 1.875
2015-10-28 2015-10-28 4 MARTELL RON KBIO Stock Option (right to buy) A - Award D 1,90 3.125 3.125
2015-10-08 2015-10-08 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 2,31 1.875 1.875
2015-09-28 2015-09-28 4 MARTELL RON KBIO Stock Option (right to buy) A - Award D 1,93 3.125 3.125
2015-09-22 2015-08-28 4 MARTELL RON KBIO Stock Option (right to buy) A - Award D 2,01 3.125 3.125
2015-09-22 2015-09-08 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 3,45 1.875 1.875
2015-08-11 2015-08-10 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 2,05 1.875 1.875
2015-07-30 2015-07-30 4 MARTELL RON KBIO Stock Option (right to buy) A - Award D 2,16 3.125 3.125
2015-07-14 2015-07-10 4 Smaldone Alsup Laurie KBIO Stock Option (right to buy) A - Award D 3,68 5.000 5.000
2015-07-14 2015-07-10 4 BAFFI ROBERT KBIO Stock Option (right to buy) A - Award D 3,68 5.000 5.000
2015-07-14 2015-07-10 4 GILBERT DENISE KBIO Stock Option (right to buy) A - Award D 3,68 5.000 5.000
2015-07-14 2015-07-10 4 WITHY RAYMOND M KBIO Stock Option (right to buy) A - Award D 3,68 5.000 5.000
2015-07-14 2015-07-10 4 LOVE TED W KBIO Stock Option (right to buy) A - Award D 3,68 5.000 5.000
2015-07-14 2015-07-10 4 LYONS GARY A KBIO Stock Option (right to buy) A - Award D 3,68 5.000 5.000
2015-07-08 2015-07-07 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,49 15.000 15.000
2015-06-30 2015-06-29 4 MARTELL RON KBIO Stock Option (right to buy) A - Award D 0,49 25.000 25.000
2015-06-08 2015-06-08 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,57 15.000 15.000
2015-05-28 2015-05-28 4 MARTELL RON KBIO Stock Option (right to buy) A - Award D 0,53 25.000 25.000
2015-05-08 2015-05-07 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,50 15.000 15.000
2015-04-27 2015-04-22 4 MARTELL RON KBIO Stock Option (right to buy) A - Award D 0,57 30.000 30.000
2015-04-27 2015-04-22 4 MARTELL RON KBIO Restricted Stock Units A - Award D 30.000 30.000
2015-04-08 2015-04-07 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,47 15.000 15.000
2015-03-13 2015-01-20 4/A CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,44 15.000 15.000
2015-03-10 2015-03-10 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,56 15.000 15.000
2015-02-18 2015-02-16 4 Joseph Donald KBIO Stock Options (right to buy) A - Award D 0,45 300.000 300.000
2015-02-18 2015-02-16 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,45 300.000 300.000
2015-02-18 2015-02-16 4 Yarranton Geoffrey Thomas KBIO Stock Options (right to buy) A - Award D 0,45 300.000 300.000
2015-02-09 2015-02-06 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,42 15.000 15.000
2015-01-21 2015-01-20 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 0,44 15.000 15.000
2014-12-01 2014-11-25 4 BAFFI ROBERT KBIO Stock Option (right to buy) A - Award D 1,87 40.000 40.000
2014-06-20 2014-06-18 4 LOVE TED W KBIO Stock Option (right to buy) A - Award D 2,10 20.000 20.000
2014-06-20 2014-06-18 4 LAWLIS V BRYAN KBIO Stock Option (right to buy) A - Award D 2,10 20.000 20.000
2014-06-20 2014-06-18 4 WITHY RAYMOND M KBIO Stock Option (right to buy) A - Award D 2,10 20.000 20.000
2014-06-20 2014-06-18 4 LYONS GARY A KBIO Stock Option (right to buy) A - Award D 2,10 20.000 20.000
2014-06-20 2014-06-18 4 GILBERT DENISE KBIO Stock Option (right to buy) A - Award D 2,10 20.000 20.000
2014-06-20 2014-06-18 4 Smaldone Alsup Laurie KBIO Stock Option (right to buy) A - Award D 2,10 20.000 20.000
2014-01-22 2014-01-19 4 Joseph Donald KBIO Stock Option (right to buy) A - Award D 5,41 40.000 40.000
2014-01-22 2014-01-19 4 Yarranton Geoffrey Thomas KBIO Stock Option (right to buy) A - Award D 5,41 75.000 75.000
2014-01-22 2014-01-19 4 Molfino Nestor KBIO Stock Option (right to buy) A - Award D 5,41 150.000 150.000
2014-01-22 2014-01-21 4 Pritchard David KBIO Stock Option (right to buy) A - Award D 5,36 250.000 250.000
2013-10-23 2013-10-22 4 CROSS HERB KBIO Stock Option (right to buy) A - Award D 4,15 150.000 150.000
2013-10-23 2013-10-22 4 Smaldone Alsup Laurie KBIO Stock Option (right to buy) A - Award D 4,15 20.000 20.000
2013-09-03 2013-08-29 4 LAWLIS V BRYAN KBIO Stock Option (right to buy) A - Award D 5,57 20.000 20.000
2013-08-01 2013-07-30 4 Joseph Donald KBIO Stock Option (right to buy) A - Award D 5,75 125.000 125.000
2013-05-03 2013-05-01 4 HENNER DENNIS KBIO Stock Option (Right to Buy) A - Award D 6,00 15.000 15.000
2013-05-02 2013-04-30 4 HEALY JAMES KBIO Stock Option (right to buy) A - Award D 6,00 15.000 15.000
2013-05-02 2013-04-30 4 WITHY RAYMOND M KBIO Stock Option (right to buy) A - Award D 6,00 15.000 15.000
2013-05-02 2013-04-30 4 LOVE TED W KBIO Stock Option (right to buy) A - Award D 6,00 15.000 15.000
2013-05-02 2013-04-30 4 LYONS GARY A KBIO Stock Option (right to buy) A - Award D 6,00 15.000 15.000
2013-05-02 2013-04-30 4 GILBERT DENISE KBIO Stock Option (right to buy) A - Award D 6,00 15.000 15.000
2013-05-02 2013-04-30 4 Cooper Jeffrey H KBIO Stock Option (right to buy) A - Award D 6,00 -60.000 60.000
2013-05-02 2013-04-30 4 Molfino Nestor KBIO Stock Option (right to buy) A - Award D 6,00 -90.000 90.000
2013-05-02 2013-04-30 4 Yarranton Geoffrey Thomas KBIO Stock Option (right to buy) A - Award D 6,00 75.000 75.000
2013-05-02 2013-04-30 4 Smith Brigitte KBIO Stock Option (right to buy) A - Award D 6,00 15.000 15.000
2013-05-02 2013-04-30 4 Pritchard David KBIO Stock Option (right to buy) A - Award D 6,00 150.000 150.000
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series E Preferred Stock C - Conversion I -1.207 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series E Preferred Stock C - Conversion I -80.731 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series E Preferred Stock C - Conversion I -643 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series D Preferred Stock C - Conversion I -2.565 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series D Preferred Stock C - Conversion I -171.450 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series D Preferred Stock C - Conversion I -1.367 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series C Preferred Stock C - Conversion I -3.143 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series C Preferred Stock C - Conversion I -210.056 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series C Preferred Stock C - Conversion I -1.675 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series B-2 Preferred Stock C - Conversion I -9.982 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series B-2 Preferred Stock C - Conversion I -653.356 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series B-2 Preferred Stock C - Conversion I -19.120 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series B-1 Preferred Stock C - Conversion I -5.231 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series B-1 Preferred Stock C - Conversion I -341.236 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series B-1 Preferred Stock C - Conversion I -11.226 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series A Preferred Stock C - Conversion I -2.851 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series A Preferred Stock C - Conversion I -185.996 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Series A Preferred Stock C - Conversion I -6.118 0
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 1.392 31.415
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 93.129 2.072.914
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 742 43.767
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 2.918 30.023
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 195.088 1.979.785
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 1.555 43.025
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 3.440 27.105
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 229.904 1.784.697
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 1.833 41.470
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 9.982 23.665
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 653.356 1.554.793
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 19.120 39.637
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 5.231 13.683
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 341.236 901.437
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 11.226 20.517
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 2.851 8.452
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 185.996 560.201
2013-02-07 2013-02-05 4 HEALY JAMES KBIO Common Stock C - Conversion I 6.118 9.291
2013-02-07 2013-02-05 4 DEVELOPMENT BANK OF JAPAN INC. KBIO Series D Preferred Stock C - Conversion D -431.973 0
2013-02-07 2013-02-05 4 DEVELOPMENT BANK OF JAPAN INC. KBIO Common Stock C - Conversion D 491.530 491.530
2013-02-07 2013-02-05 4 BAXTER INTERNATIONAL INC KBIO Series D Preferred Stock C - Conversion D -842.435 0
2013-02-07 2013-02-05 4 BAXTER INTERNATIONAL INC KBIO Common Stock C - Conversion D 958.583 958.583
2013-02-07 2013-02-05 4 Sanofi by wholly-owned subsidiary Genzyme Corp. KBIO Preferred Shares C - Conversion I -431.973 0
2013-02-07 2013-01-31 4 Sanofi by wholly-owned subsidiary Genzyme Corp. KBIO Common Stock P - Purchase I 8,0000 87.500 700 579.030
2013-02-07 2013-02-05 4 HENNER DENNIS KBIO Series D Preferred Stock C - Conversion I -275.539 0
2013-02-07 2013-02-05 4 HENNER DENNIS KBIO Series C Preferred Stock C - Conversion I -337.622 0
2013-02-07 2013-02-05 4 HENNER DENNIS KBIO Series B-2 Preferred Stock C - Conversion I -1.949.879 0
2013-02-07 2013-02-05 4 HENNER DENNIS KBIO Common Stock C - Conversion I 313.527 2.632.928
2013-02-07 2013-02-05 4 HENNER DENNIS KBIO Common Stock C - Conversion I 369.522 2.319.401
2013-02-07 2013-02-05 4 HENNER DENNIS KBIO Common Stock C - Conversion I 1.949.879 1.949.879
2013-02-07 2013-02-05 4 EVNIN LUKE KBIO Series D Preferred Stock C - Conversion I -275.539 0
2013-02-07 2013-02-05 4 EVNIN LUKE KBIO Series C Preferred Stock C - Conversion I -337.622 0
2013-02-07 2013-02-05 4 EVNIN LUKE KBIO Series B-2 Preferred Stock C - Conversion I -1.949.879 0
2013-02-07 2013-02-05 4 EVNIN LUKE KBIO Common Stock C - Conversion I 313.527 2.632.928
2013-02-07 2013-02-05 4 EVNIN LUKE KBIO Common Stock C - Conversion I 369.522 2.319.401
2013-02-07 2013-02-05 4 EVNIN LUKE KBIO Common Stock C - Conversion I 1.949.879 1.949.879
2013-02-07 2013-02-05 4 Alloy Ventures 2000, LLC KBIO Series E Preferred Stock C - Conversion D -165.164 0
2013-02-07 2013-02-05 4 Alloy Ventures 2000, LLC KBIO Series D Preferred Stock C - Conversion D -224.029 0
2013-02-07 2013-02-05 4 Alloy Ventures 2000, LLC KBIO Series C Preferred Stock C - Conversion D -181.114 0
2013-02-07 2013-02-05 4 Alloy Ventures 2000, LLC KBIO Series B-2 Preferred Stock C - Conversion D -487.489 0
2013-02-07 2013-02-05 4 Alloy Ventures 2000, LLC KBIO Series B-1 Preferred Stock C - Conversion D -357.693 0
2013-02-07 2013-02-05 4 Alloy Ventures 2000, LLC KBIO Series A Preferred Stock C - Conversion D -194.965 0
2013-02-07 2013-02-05 4 Alloy Ventures 2000, LLC KBIO Common Stock C - Conversion D 1.683.817 1.691.794
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Series D Preferred Stock C - Conversion I -275.539 0
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Series C Preferred Stock C - Conversion I -337.622 0
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Series B-2 Preferred Stock C - Conversion I -1.949.879 0
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Common Stock C - Conversion I 313.527 2.632.928
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Common Stock C - Conversion I 369.522 2.319.401
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Common Stock C - Conversion I 1.949.879 1.949.879
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Series D Preferred Stock C - Conversion I -275.539 0
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Series C Preferred Stock C - Conversion I -337.622 0
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Series B-2 Preferred Stock C - Conversion I -1.949.879 0
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Common Stock C - Conversion I 313.527 2.632.928
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Common Stock C - Conversion I 369.522 2.319.401
2013-02-07 2013-02-05 4 MPM BIOVENTURES III-QP L.P. KBIO Common Stock C - Conversion I 1.949.879 1.949.879
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series E Preferred Stock C - Conversion D -1.207 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series E Preferred Stock C - Conversion D -80.731 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series E Preferred Stock C - Conversion D -643 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series D Preferred Stock C - Conversion D -2.565 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series D Preferred Stock C - Conversion D -171.450 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series D Preferred Stock C - Conversion D -1.367 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series C Preferred Stock C - Conversion D -3.143 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series C Preferred Stock C - Conversion D -210.056 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series C Preferred Stock C - Conversion D -1.675 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series B-2 Preferred Stock C - Conversion D -9.982 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series B-2 Preferred Stock C - Conversion D -653.356 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series B-2 Preferred Stock C - Conversion D -19.120 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series B-1 Preferred Stock C - Conversion D -5.231 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series B-1 Preferred Stock C - Conversion D -341.236 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series B-1 Preferred Stock C - Conversion D -11.226 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series A Preferred Stock C - Conversion D -2.851 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series A Preferred Stock C - Conversion D -185.996 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Series A Preferred Stock C - Conversion D -6.118 0
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 1.392 31.415
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 93.129 2.072.914
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 742 43.767
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 2.918 30.023
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 195.088 1.979.785
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 1.555 43.025
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 3.440 27.105
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 229.904 1.784.697
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 1.833 41.470
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 9.982 23.665
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 653.356 1.554.793
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 19.120 39.637
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 5.231 13.683
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 341.236 901.437
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 11.226 20.517
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 2.851 8.452
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 185.996 560.201
2013-02-07 2013-02-05 4 SOFINNOVA VENTURE PARTNERS V LP KBIO Common Stock C - Conversion D 6.118 9.291
2013-02-07 2013-02-05 4 Smith Brigitte By GBS Genesis KBIO Series D Preferred Stock C - Conversion I -45.368 0
2013-02-07 2013-02-05 4 Smith Brigitte By GBS Bioventures II A/C KBIO Series D Preferred Stock C - Conversion I -170.617 0
2013-02-07 2013-02-05 4 Smith Brigitte By GBS Genesis KBIO Series C Preferred Stock C - Conversion I -25.322 0
2013-02-07 2013-02-05 4 Smith Brigitte By GBS Bioventures II A/C KBIO Series C Preferred Stock C - Conversion I -59.084 0
2013-02-07 2013-02-05 4 Smith Brigitte By GBS Genesis KBIO Series B-2 Preferred Stock C - Conversion I -146.240 0
2013-02-07 2013-02-05 4 Smith Brigitte By GBS Bioventures II A/C KBIO Series B-2 Preferred Stock C - Conversion I -341.229 0
2013-02-07 2013-02-05 4 Smith Brigitte KBIO Common Stock C - Conversion I 825.613 850.613
2013-02-07 2013-02-05 4 5AM Partners LLC KBIO Series D Preferred Stock C - Conversion D -96.612 0
2013-02-07 2013-02-05 4 5AM Partners LLC KBIO Series C Preferred Stock C - Conversion D -79.886 0
2013-02-07 2013-02-05 4 5AM Partners LLC KBIO Series B-2 Preferred Stock C - Conversion D -175.488 0
2013-02-07 2013-02-05 4 5AM Partners LLC KBIO Series B-1 Preferred Stock C - Conversion D -125.185 0
2013-02-07 2013-02-05 4 5AM Partners LLC KBIO Common Stock C - Conversion D 498.038 721.228
2013-02-07 2013-02-05 4 Mitsubishi UFJ Capital II, Limited Partnership KBIO Series D Preferred Stock C - Conversion D -345.578 0
2013-02-07 2013-02-05 4 Mitsubishi UFJ Capital II, Limited Partnership KBIO Common Stock C - Conversion D 393.223 393.223
2013-02-07 2013-02-05 4 GBS Venture Partners Pty, Ltd KBIO Series D Preferred Stock C - Conversion D -215.985 0
2013-02-07 2013-02-05 4 GBS Venture Partners Pty, Ltd KBIO Series C Preferred Stock C - Conversion D -84.406 0
2013-02-07 2013-02-05 4 GBS Venture Partners Pty, Ltd KBIO Series B-2 Preferred Stock C - Conversion D -487.469 0
2013-02-07 2013-02-05 4 GBS Venture Partners Pty, Ltd KBIO Common Stock C - Conversion D 825.613 850.613
2013-02-07 2013-02-05 4 Lehman Brothers Holdings Inc. By LB I Group Inc. KBIO Series C Convertible Preferred Stock C - Conversion I -974.940 0
2013-02-07 2013-02-05 4 Lehman Brothers Holdings Inc. By LB I Group Inc. KBIO Common Stock C - Conversion I 1.067.059 1.067.059
2013-02-07 2013-02-05 4 SINGAPORE BIO INNOVATIONS PTE LTD KBIO Series D Preferred Stock C - Conversion D -104.387 0
2013-02-07 2013-02-05 4 SINGAPORE BIO INNOVATIONS PTE LTD KBIO Series C Preferred Stock C - Conversion D -51.710 0
2013-02-07 2013-02-05 4 SINGAPORE BIO INNOVATIONS PTE LTD KBIO Series B-2 Preferred Stock C - Conversion D -175.489 0
2013-02-07 2013-02-05 4 SINGAPORE BIO INNOVATIONS PTE LTD KBIO Series B-1 Preferred Stock C - Conversion D -121.149 0
2013-02-07 2013-02-05 4 SINGAPORE BIO INNOVATIONS PTE LTD KBIO Common Stock C - Conversion D 472.013 474.018
2013-02-04 2013-01-31 4 HEALY JAMES KBIO Common Stock P - Purchase I 8,0000 5.485 44 5.601
2013-02-04 2013-01-31 4 HEALY JAMES KBIO Common Stock P - Purchase I 8,0000 366.592 2.933 374.205
2013-02-04 2013-01-31 4 HEALY JAMES KBIO Common Stock P - Purchase I 8,0000 2.923 23 3.173
2013-02-04 2013-01-31 4 GBS Venture Partners Pty, Ltd KBIO Common Stock P - Purchase D 8,0000 25.000 200 25.000
2013-02-04 2013-01-31 4 Smith Brigitte By GBS Bioventures II A/C KBIO Common Stock P - Purchase I 8,0000 25.000 200 25.000
2013-02-04 2013-01-31 4 5AM Partners LLC KBIO Common Stock P - Purchase D 8,0000 62.500 500 223.190
2012-08-13 3 WITHY RAYMOND M NONE Common Stock D 100.000
2012-08-10 3 Alloy Ventures 2000, L.P. NONE Common Stock D 28.418
2012-08-10 3 Azan Alain NONE Common Stock I 414
2012-08-10 3 Azan Alain NONE Common Stock I 27.116
2012-08-10 3 Azan Alain NONE Common Stock I 891
2012-08-10 3 Yarranton Geoffrey Thomas NONE Common Stock D 931.645
2012-08-10 3 Pritchard David NONE Common Stock D 2.273.521
2012-08-10 3 Shochat Dan NONE Common Stock D 826.394
2012-08-10 3 5AM VENTURES LLC NONE Common Stock D 572.295
2012-08-10 3 EDB Investments Pte Ltd. NONE Common Stock D 7.142
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista